| Product Code: ETC7601898 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Iraq Artificial Intelligence (AI) in Drug Discovery Market Overview |
3.1 Iraq Country Macro Economic Indicators |
3.2 Iraq Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, 2021 & 2031F |
3.3 Iraq Artificial Intelligence (AI) in Drug Discovery Market - Industry Life Cycle |
3.4 Iraq Artificial Intelligence (AI) in Drug Discovery Market - Porter's Five Forces |
3.5 Iraq Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Iraq Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Iraq Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Iraq Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume Share, By Offering, 2021 & 2031F |
3.9 Iraq Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.10 Iraq Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Iraq Artificial Intelligence (AI) in Drug Discovery Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for innovative drug discovery solutions |
4.2.2 Government support and initiatives to promote AI technologies in healthcare |
4.2.3 Growing investments in AI technology by pharmaceutical companies |
4.3 Market Restraints |
4.3.1 Lack of skilled professionals in AI and drug discovery |
4.3.2 Data privacy and security concerns related to AI in healthcare |
5 Iraq Artificial Intelligence (AI) in Drug Discovery Market Trends |
6 Iraq Artificial Intelligence (AI) in Drug Discovery Market, By Types |
6.1 Iraq Artificial Intelligence (AI) in Drug Discovery Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Iraq Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Iraq Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Novel Drug Candidates, 2021- 2031F |
6.1.4 Iraq Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Drug Optimization and Repurposing Preclinical Testing and Approval, 2021- 2031F |
6.1.5 Iraq Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Drug Monitoring, 2021- 2031F |
6.1.6 Iraq Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Aggregating and Synthesizing Information, 2021- 2031F |
6.1.7 Iraq Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Formation and Qualification of Hypotheses, 2021- 2031F |
6.1.8 Iraq Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By De Novo Drug Design, 2021- 2031F |
6.1.9 Iraq Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 Iraq Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Iraq Artificial Intelligence (AI) in Drug Discovery Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Iraq Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Machine Learning, 2021- 2031F |
6.2.3 Iraq Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Deep Learning, 2021- 2031F |
6.2.4 Iraq Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Natural Language Processing, 2021- 2031F |
6.2.5 Iraq Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Iraq Artificial Intelligence (AI) in Drug Discovery Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Iraq Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Small Molecule, 2021- 2031F |
6.3.3 Iraq Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Large Molecule, 2021- 2031F |
6.4 Iraq Artificial Intelligence (AI) in Drug Discovery Market, By Offering |
6.4.1 Overview and Analysis |
6.4.2 Iraq Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Software, 2021- 2031F |
6.4.3 Iraq Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Services, 2021- 2031F |
6.5 Iraq Artificial Intelligence (AI) in Drug Discovery Market, By Indication |
6.5.1 Overview and Analysis |
6.5.2 Iraq Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Immuno-Oncology, 2021- 2031F |
6.5.3 Iraq Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Neurodegenerative Diseases, 2021- 2031F |
6.5.4 Iraq Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.5.5 Iraq Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Metabolic Diseases, 2021- 2031F |
6.5.6 Iraq Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Iraq Artificial Intelligence (AI) in Drug Discovery Market, By End Use |
6.6.1 Overview and Analysis |
6.6.2 Iraq Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Contract Research Organizations (CROs), 2021- 2031F |
6.6.3 Iraq Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Pharmaceutical and Biotechnology Companies, 2021- 2031F |
6.6.4 Iraq Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Research Centers and Academic Institutes, 2021- 2031F |
6.6.5 Iraq Artificial Intelligence (AI) in Drug Discovery Market Revenues & Volume, By Others, 2021- 2031F |
7 Iraq Artificial Intelligence (AI) in Drug Discovery Market Import-Export Trade Statistics |
7.1 Iraq Artificial Intelligence (AI) in Drug Discovery Market Export to Major Countries |
7.2 Iraq Artificial Intelligence (AI) in Drug Discovery Market Imports from Major Countries |
8 Iraq Artificial Intelligence (AI) in Drug Discovery Market Key Performance Indicators |
8.1 Number of research collaborations between AI companies and pharmaceutical firms |
8.2 Growth in the number of AI patents related to drug discovery filed in Iraq |
8.3 Increase in the adoption rate of AI-powered drug discovery tools by healthcare institutions |
9 Iraq Artificial Intelligence (AI) in Drug Discovery Market - Opportunity Assessment |
9.1 Iraq Artificial Intelligence (AI) in Drug Discovery Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Iraq Artificial Intelligence (AI) in Drug Discovery Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Iraq Artificial Intelligence (AI) in Drug Discovery Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Iraq Artificial Intelligence (AI) in Drug Discovery Market Opportunity Assessment, By Offering, 2021 & 2031F |
9.5 Iraq Artificial Intelligence (AI) in Drug Discovery Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.6 Iraq Artificial Intelligence (AI) in Drug Discovery Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 Iraq Artificial Intelligence (AI) in Drug Discovery Market - Competitive Landscape |
10.1 Iraq Artificial Intelligence (AI) in Drug Discovery Market Revenue Share, By Companies, 2024 |
10.2 Iraq Artificial Intelligence (AI) in Drug Discovery Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here